Kenalog Spray

  • Topical steroids

Kenalog Spray Generic Name & Formulations

General Description

Triamcinolone acetonide 0.2%.

Pharmacological Class


How Supplied


Generic Availability


Kenalog Spray Indications


Corticosteroid-responsive dermatoses.

Kenalog Spray Dosage and Administration

Adults and Children

Apply sparingly 3–4 times daily.

Kenalog Spray Contraindications

Not Applicable

Kenalog Spray Boxed Warnings

Not Applicable

Kenalog Spray Warnings/Precautions


Not for oral, ophthalmic, or intravaginal use. Avoid use on face, axilla, or groin. Do not use on pre-existing skin atrophy. Risk of HPA axis suppression with high-potency steroids, prolonged use, application to large surface area, use of occlusive dressings, altered skin barrier, liver failure, young age; discontinue gradually, reduce dose, or substitute with less potent corticosteroid if occurs. Treat infection if present; discontinue if infection persists or worsens. Use lowest effective dose and potency (esp. in children). Flammable. Avoid abrupt cessation in chronic use. Reevaluate periodically. Pregnancy (Cat.C). Nursing mothers.

Kenalog Spray Pharmacokinetics

See Literature

Kenalog Spray Interactions

Not Applicable

Kenalog Spray Adverse Reactions

Adverse Reactions

Burning, itching, irritation, dryness, folliculitis, hypertrichosis, acneiform eruptions, hypopigmentation, perioral dermatitis, skin maceration, secondary infection, skin atrophy, striae, miliaria; allergic contact dermatitis (discontinue if irritation occurs), HPA axis suppression (esp. in children); rare: Cushing's syndrome, hyperglycemia.

Kenalog Spray Clinical Trials

See Literature

Kenalog Spray Note

Not Applicable

Kenalog Spray Patient Counseling

See Literature